Table 1. Clinical and socio-demographic information and questionnaire scores of consenting group.
| Characteristic | Number of participants |
|---|---|
| Age groups | |
| ⩽40 years | 112 |
| 41–60 years | 262 |
| ⩾61 years | 235 |
| Sex | |
| Males | 304 |
| Females | 305 |
| Carstairs and Morris index groups a | |
| Affluent group (score range −4.51 to −0.86) | 283 |
| Deprived group (score range −0.77 to 12.44) | 293 |
| Diagnosis | |
| Head and neck | 53 |
| Lung | 47 |
| Genito-urinary | 45 |
| Germ cell | 60 |
| Haematological | 83 |
| Gastro-intestinal | 93 |
| Breast | 104 |
| Gynacological | 70 |
| Sarcoma | 19 |
| Melanoma | 29 |
| Brain | 4 |
| Unknown primary | 2 |
| Stage of disease | |
| Survivorsb | 94 |
| Disease free (diagnosed within last two years) | 176 |
| Primary local | 125 |
| Local recurrent | 22 |
| Metastatic | 143 |
| Otherc | 49 |
| Hospital Anxiety and Depression Scale (HADS) d | |
| Low level distress group (sum score <13) | 274 |
| High level distress group (sum score ⩾13) | 334 |
| Social Difficulties Inventory (SDI) | |
| Low level of difficulty group (sum score <9) | 334 |
| High level difficulty group (sum score ⩾9) | 275 |
a
Carstairs and Morris scores were available for 576 participants (33 missing values).
b
Disease free diagnosed more than 2 years ago.
c
Includes people with advanced ovarian and haematological malignancies which cannot be classified using the other categories.
d
One participant had missing data from the HADS.